![]() |
Rob JonesDirector, Professional Services, Cencora Pharmalex |
While regulators have embraced risk-based approaches across clinical development, organizations are still struggling to find the right balance of risk vs. return when it comes to the Trial Master File. Our experts walk you through how to manage and resolve the often conflicting internal and external directives to find the right path for you.